ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
0.00
0.00%
US Tech 100
21,214.46
1.06%
다우존스 지수
44,156.73
0.30%
Bitcoin
102,340.78
-1.25%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 영국
  5. LSE

  6. Pihlajalinna Oyj (0R8H) 시세

Pihlajalinna Oyj

Pihlajalinna Oyj (0R8H)

LSE
12.90
0.00
(0.00%)
마감 23 1월 1:30AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
12.90
매수가
0.00
매도가
0.00
거래량
904
0.00 일간 변동폭 0.00
12.90 52주 범위 12.90
market_cap
291.101M
전일 종가
12.90
개장가
-
최근 거래 시간
100
@
10.15
(O)
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
292
발행 주식
22,566,000
배당수익률
-
주가수익률
50.81
주당순이익(EPS)
0.25
매출
727.29M
순이익
5.73M

Pihlajalinna Oyj 정보

섹터
Offices Of Medical Doctors
산업
Offices Of Medical Doctors
웹사이트
www.pihlajalinna.fi
본부
Tampere, Fin
설립됨
-
Pihlajalinna Oyj is listed in the Offices Of Medical Doctors sector of the 런던증권거래소 with ticker 0R8H. The last closing price for Pihlajalinna Oyj was 12.90 €. Over the last year, Pihlajalinna Oyj shares have traded in a share price range of 12.90 € to 12.90 €.

Pihlajalinna Oyj currently has 22,566,000 shares in issue. The market capitalisation of Pihlajalinna Oyj is 291.10 € million. Pihlajalinna Oyj has a price to earnings ratio (PE ratio) of 50.81.

0R8H 최신 뉴스

추가 뉴스
No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10012.912.912.977212.9DE
40012.912.912.959312.9DE
120012.912.912.929212.9DE
260012.912.912.913012.9DE
520012.912.912.96712.9DE
1560012.912.912.929112.9DE
2600012.912.912.925112.9DE

0R8H - Frequently Asked Questions (FAQ)

What is the current Pihlajalinna Oyj share price?
The current share price of Pihlajalinna Oyj is 12.90 €
How many Pihlajalinna Oyj shares are in issue?
Pihlajalinna Oyj has 22,566,000 shares in issue
What is the market cap of Pihlajalinna Oyj?
The market capitalisation of Pihlajalinna Oyj is EUR 291.1M
What is the 1 year trading range for Pihlajalinna Oyj share price?
Pihlajalinna Oyj has traded in the range of 12.90 € to 12.90 € during the past year
What is the PE ratio of Pihlajalinna Oyj?
The price to earnings ratio of Pihlajalinna Oyj is 50.81
What is the cash to sales ratio of Pihlajalinna Oyj?
The cash to sales ratio of Pihlajalinna Oyj is 0.4
What is the reporting currency for Pihlajalinna Oyj?
Pihlajalinna Oyj reports financial results in EUR
What is the latest annual turnover for Pihlajalinna Oyj?
The latest annual turnover of Pihlajalinna Oyj is EUR 727.29M
What is the latest annual profit for Pihlajalinna Oyj?
The latest annual profit of Pihlajalinna Oyj is EUR 5.73M
What is the registered address of Pihlajalinna Oyj?
The registered address for Pihlajalinna Oyj is KEHRASAARI B, 4TH FLOOR, TAMPERE, 33200
What is the Pihlajalinna Oyj website address?
The website address for Pihlajalinna Oyj is www.pihlajalinna.fi
Which industry sector does Pihlajalinna Oyj operate in?
Pihlajalinna Oyj operates in the OFFICES OF MEDICAL DOCTORS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
EXREngage Xr Holdings Plc
2.00p
(190.91%)
94M
LLAILunglife Ai Inc
11.75p
(30.56%)
1.16M
TM1Technology Minerals Plc
0.14p
(27.27%)
78.39M
PYCPhysiomics Plc
1.05p
(27.27%)
41.18M
VASTVast Resources Plc
0.1325p
(26.19%)
245.04M
TRCThe Revel Collective Plc
0.275p
(-31.25%)
7.26M
MILAMila Resources Plc
0.225p
(-30.77%)
41.77M
MODER8 Capital Investments Plc
1.65p
(-26.67%)
5.59M
HOCHochschild Mining Plc
190.80p
(-16.68%)
9.86M
STKStreaksai Plc
1.05p
(-16.00%)
1.06M
NTVONativo Resources Plc
0.0021p
(5.00%)
1.33B
TRPTower Resources Plc
0.0295p
(-3.28%)
443.63M
PREMPremier African Minerals Limited
0.0255p
(-4.14%)
435.82M
SYMESupply@me Capital Plc
0.0031p
(-7.46%)
392.02M
RRRRed Rock Resources Plc
0.06p
(20.00%)
312.39M

토론

전체 피드 보기
ThoroughBread ThoroughBread 4 분 전
SFIO .0028 sleeper.
SFIO
glens0 glens0 5 분 전
CTOR last Aug. 6th the price was $49.00 now $1.32
CTOR
ThoroughBread ThoroughBread 7 분 전
SING @ .006 bounce-pop off this level. Daily volume increasing.
boi568 boi568 8 분 전
Yes, it's also true that guidelines allow for more discretion than rules. To a point.

If the governing science that applies to two applicants is the same, the FDA decisional criteria should be the same. In this case, if the AD stages in the trials are the same, the endpoints should be
AVXL
Hardazoak Hardazoak 9 분 전
Current Aabbg works fine, wallet works fine. New aabb wallet 2.0 with AI and moonpay exchange integrated coming. Stop with the lies gitreal, only you are believing your own lies.
AABB
KPIFF-LDDFF KPIFF-LDDFF 9 분 전
KPIFF
wadegarret wadegarret 9 분 전
Novice- AI stocks have mostly done their thing

I don't believe Stargate will add all that much to boost valuations further. I mean NVDA already sells for over a 30 something PE going forward, CRDO sells for an 85 PE going forward, CRWD sells for around an 80 PE going forward, PLTR
AES CRDO CRWD
PEACHMAN PEACHMAN 10 분 전
The exact opposite of what you say is true.LOLOLOLOL!!!!! I OWN you, kitty. Heart, mind, body and soul!! You fall into traps, you copy verbatim my posts. Have you ever had an independent thought in your life?

https://investorshub.advfn.com/uimage/uploads/2025/1/22/sdlmono_panther.pn
IFUS
pinhigh pinhigh 10 분 전
Well done video gimmee! RRX!
BIEL
Orange Cassidy Orange Cassidy 12 분 전
The Jared "whisperer" is still here in emoji form on every post. He has not gone anywhere. As it stands the mills are abandoned and this is still a sham. "Whats not to like?"
NBRI
bas2020 bas2020 12 분 전
Any shorting after approval will be total manipulation by the corrupt cabal... your bosses. Hopefully, we'll have MTD denial prior with a cease and desist order to go with it... to cut ya all off at the knees. 💥
NWBO
hssbwwmp hssbwwmp 12 분 전
Yes, I've seen them cite those factors in their reports as well as being flexible to adapt to them. So, it would seem that if AXXA was still able to grow revenue and reduce debt despite those factors, then the PPS should not have continued this long downtrend, correct? Something still is not comp
AXXA
RichieBoy RichieBoy 13 분 전
Minute 28 - Minute 40 is on AI

Keep in mind this is acutely political. So you'll be left wondering about this side of AI and oh that part of AI why aren't they important. They are important of course, but never before to date will you have seen such intense focus on this one facet.
AFFU
boarddork boarddork 14 분 전
That’s a lot of push pins and zig zag strings to make that ultimate conclusion.
COOP
weedtrader420 weedtrader420 15 분 전
BITCOIN XRP TRIUMPH MAGIC POWER $120,000 TARGET
BTCUSD
janice shell janice shell 15 분 전
She's one of the very few who actually deserves a pardon.
Hoskuld Hoskuld 16 분 전
This is not really true Boi - although I can imagine that logically it should be true. But, no 2 companies run their trials the same way. Usually. this is deliberate. The FDA cannot evaluate them the same way, as a result. The guidelines are NOT requirements. They are simply suggestions.
AVXL
StayHumble StayHumble 17 분 전
wow💹100% Xpert SHORT interest💹significant evidence of SHORTS💹💹 huzzah!!!
HMBL
WALL STREET KID WALL STREET KID 18 분 전
$AMC 5B SWAPS EXPIRING! SHORTS AT RISK! Short Squeeze Update

https://youtu.be/eUD6PpQ-Oxw?si=QpOWsGLt0b2Qu2s6
AMC
vinmantoo vinmantoo 20 분 전
Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.
WhAtEvA1 WhAtEvA1 21 분 전
With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.
RDGL
glens0 glens0 21 분 전
$CTOR Not to many shares left in the market. Should go up real fast when good news comes out. And it should be soon.
Total Insider Shares Held 64.72M
Citius Oncology Annual Shares Outstanding
(Millions of Shares)
2024 68M
CTOR
Zorch305 Zorch305 22 분 전
Whats 305
RNVA

최근 히스토리

LSE
0R8H
Pihlajalinna Oyj
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유